Close Menu

NEW YORK (360Dx) – Molecular diagnostics firm Co-Diagnostics anticipates raising up to $8.5 million in net proceeds in a public offering of its stock, the firm said in an amended prospectus filed with the US Securities and Exchange Commission on Monday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.